Dexcom G6 CGM System
Device Endocrinology
General payments
$1,281,255
Research payments
$3,677,759
Through program year 2020, $1,281,255 in general payments and $3,677,759 in research payments were reported against Dexcom G6 CGM System (Endocrinology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $1,281,255 | 3,860 |
| 2020 | Research | $2,360,346 | 462 |
| 2019 | Research | $1,317,412 | 71 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.
The top 5 of 26 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2020 where a state was reported.
Records
3,860 general · 533 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.